Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN PATHS) study

摘要 自我污名是影响OUD治疗参与和保留的许多障碍之一， 可能会导致从惩教机构释放后过量服用的高风险。识别 缓解和改变释放后阿片类药物相关过量死亡风险的因素可能会导致 新的干预措施和方案的机会。在患有 物质使用障碍（SUD）已经确定了对制定污名恐惧，以及自我污名， 阻碍治疗进入和参与的诱发因素。自我污名如何影响 没有研究过从监狱释放后从事OUD治疗的情况。知之甚少， 以病人为中心的初级保健模式是否可以改善自我羞辱，以及这是否， 反过来，增强了改进的OUD治疗接合和保持。这项研究有助于A 新一代的药物滥用卫生服务研究出现在我们的小组，解决 自我污名对新的以病人为中心的初级保健的有效性的影响 方法，以改善健康的司法参与个人与OUD。整体研究 父母补助金（1UG1DA050072）的补充目的是检查自我教育的影响， 刚从监狱释放的个人对OUD治疗级联的耻辱感，并评估 TCN干预与释放后治疗期间自我污名减少相关 期我们的目标是：（1）确定哪些社会人口特征和心理社会，健康， 治疗因素与自我污名相关。(2)确定自我污名是否 缓和TCN参与和OUD治疗参与之间的关联 释放后。结果将为随后的R34测试提供初步数据， 改善自我羞辱的干预措施及其对治疗结果的影响。专业 发展计划将促进申请人的独立研究事业的实现 侧重于测试初级保健中可获得的干预模式，以减少自我羞辱， 促进这一弱势群体追求有价值的生活目标。

ABSTRACT Self-stigma is one of many barriers that affect engagement and retention in OUD treatment and may be driving the high risk of overdose following release from correctional facilities. Identifying factors that moderates and modify post-release opioid related overdose mortality risk can create opportunities for novel interventions and programs. Studies conducted among individuals with a substance use disorder (SUD) have identified fear of enacted stigma, as well as self-stigma, as predisposing factors that hinder treatment entry and engagement. How self-stigma impacts the engagement in OUD treatment following release from jail has not been studied. Less is known on whether a patient-centered primary care model can ameliorate self-stigma and whether this, in turn, enhances improved OUD treatment engagement and retention. This study contributes to a new generation of drug abuse health services research emerging in our group that addresses the effects of self-stigma on the effectiveness and patient-centeredness of a new primary care-based approach to improving the health of justice-involved individuals with OUD. The overall research objective of this supplement to parent grant (1UG1DA050072) is to examine the effects of self- stigma on the OUD treatment cascade among individuals just released from jail and assess if the TCN intervention is associated with self-stigma reductions during post release treatment period. We aim to: (1) Identify which sociodemographic characteristics and psychosocial, health, and treatment factors are associated with self-stigma. (2) Determine whether self-stigma moderates the association between TCN participation and engagement in OUD treatment following release. Results will provide preliminary data for a subsequent R34 testing an intervention to ameliorate self-stigma and its impact on treatment outcomes. The professional development plan will facilitate attainment of the applicant’s independent research career focused on testing intervention modalities accessible in primary care to reduce self-stigma and enhance pursuing valued life goals in this vulnerable population.